Delivery Order SPE2DB25D3012-SPE2DB25FWZHP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $1,126.10 and a firm fixed price contract type. This delivery order, which is expected to be completed by August 11, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,126.10. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location. This delivery order represents a child contract under...
- This delivery order, awarded on August 11, 2025, to AmerisourceBergen Drug Corp, provides Valtoco (naloxone) 15 mg nasal spray to support federal medical supply needs. The contract, valued at $10,270.32 with a firm fixed price structure, is scheduled for completion by August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency (DLA), a Department of Defense organization, is the funding federal agency. No set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,543.14. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,259.24 for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded procurement issued on July 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a specialized acute-use nasal spray medication, indicating this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,148.22 to AmerisourceBergen Drug Corp for Valtoco 20 mg nasal sprays, with an ultimate completion date of July 30, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and represents a child contract under AmerisourceBergen's larger DLA agreement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZHPDelivery Order
The Defense Logistics Agency awarded a $1,128.54 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of August 20, 2025. This firm fixed-price contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Valtoco (naloxone) nasal spray is a critical emergency medication used to rapidly reverse opioid overdoses. This delivery order reflects the federal government's continued procurement of essential pharmaceutical products through AmerisourceBergen, a major pharmaceutical distributor serving military and veteran healthcare systems. As a primary vendor for the DLA Medical Supply Chain, AmerisourceBergen maintains extensive capabilities to supply a comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support defense and federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |